Medicine and Dentistry
Acetylsalicylic Acid
67%
Coronary Artery Disease
61%
Antiplatelet
53%
Platelet
50%
Cardiovascular System
48%
Heart Muscle Ischemia
31%
Myocardial Infarction
30%
Antiplatelet Drug
26%
Clopidogrel
25%
Atrial Fibrillation
25%
Cardiovascular Disease
24%
Thrombocyte Function
24%
Thrombocyte Aggregation
23%
Antithrombotic
22%
Coronary Angiography
22%
Brain Ischemia
21%
Heart Muscle Revascularization
17%
Anticoagulation
17%
Percutaneous Coronary Intervention
16%
Hazard Ratio
13%
Acute Coronary Syndrome
12%
Receptor Antagonist
10%
Stent Thrombosis
10%
Cause of Death
9%
Thromboembolism
9%
Cohort Analysis
9%
Function Test
9%
Disease
9%
Proton-Pump Inhibitor
9%
Diabetes Mellitus
9%
Platelet Reactivity
9%
Cardiology
9%
Adenosine Diphosphate
9%
Cardiovascular Risk
8%
Genetic Risk
8%
Secondary Prevention
8%
Heart Death
8%
Drug Interaction
7%
Apoplexy
7%
Anticoagulant Therapy
7%
Selective Serotonin Reuptake Inhibitor
7%
Pharmacogenomics
7%
Cardioversion
7%
Diabetes
7%
Cohort Effect
7%
Disseminated Herpes Zoster
7%
Kidney Function
7%
Acute Lymphoblastic Leukemia
7%
Population
7%
Thrombocyte Activation
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
100%
Coronary Artery Disease
92%
Antiplatelet
65%
Heart Infarction
43%
Brain Ischemia
32%
Antithrombocytic Agent
31%
Cardiovascular Disease
30%
Anticoagulant Agent
26%
Clopidogrel
25%
Atrial Fibrillation
23%
Heart Muscle Ischemia
23%
Stent Thrombosis
19%
Cohort Study
18%
Diabetes Mellitus
17%
Menorrhagia
15%
Thrombopoietin
14%
Cause of Death
11%
Bleeding
11%
Receptor Antagonist
11%
Arachidonic Acid
10%
Acute Coronary Syndrome
10%
Genetic Risk
9%
Proton Pump Inhibitor
9%
Rivaroxaban
9%
Peripheral Occlusive Artery Disease
9%
Adenosine Diphosphate
9%
P-Selectin
8%
Monotherapy
8%
Cardiovascular Risk
8%
Brain Hemorrhage
8%
Heart Death
8%
Mortality Rate
8%
Comorbidity
7%
Pharmacogenomics
7%
Selective Serotonin Reuptake Inhibitor
7%
Receptor
7%
Thromboembolism
7%
Venous Thromboembolism
7%
Drug Interaction
7%
Inflammation
7%
Thromboxane B2
7%
Cyclooxygenase 1
5%
Major Adverse Cardiac Event
5%
Clinical Trial
5%
Biochemistry, Genetics and Molecular Biology
Cohort Study
24%
Platelet
24%
Thrombocyte Aggregation
23%
Allele
21%
Genetic Risk
19%
Genetic Divergence
16%
Premenopause
15%
Clopidogrel
15%
Genetics
13%
Thrombopoietin
13%
Single-Nucleotide Polymorphism
13%
Thrombocyte Activation
11%
Mortality Rate
9%
Population
9%
Platelet Count
8%
Cyclooxygenase
8%
Comorbidity
7%
SH2B3
7%
Pharmacogenetics
7%
Platelet Reactivity
7%
Selective Serotonin Reuptake Inhibitor
7%
Capping Phenomenon
7%
Fibrin Clot
7%
Atrial Fibrillation
7%
Glycoprotein IIb/IIIa
7%
Ecological Study
7%
Cancer Incidence
7%
Arachidonic Acid
6%
P2Y12
5%
Agonist
5%